183 related articles for article (PubMed ID: 34273518)
21. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon.
da Silva Torres MK; Lopes FT; de Lima ACR; Lima CNC; Dos Santos Brito WR; Dos Santos BC; de Sousa RS; Gomes JLC; Botelho BJS; Correa ACA; Machado LFA; Feitosa RNM; Lima SS; Vallinoto IMVC; Vallinoto ACR
Sci Rep; 2022 May; 12(1):8571. PubMed ID: 35595782
[TBL] [Abstract][Full Text] [Related]
23. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021.
Giuliano AR; Pilon-Thomas S; Schell MJ; Abrahamsen M; Islam JY; Isaacs-Soriano K; Kennedy K; Dukes CW; Whiting J; Rathwell J; Hensel JA; Mangual LN; Schonbrunn E; Bikowitz M; Grassie D; Yang Y
Emerg Infect Dis; 2022 Mar; 28(3):556-563. PubMed ID: 35081021
[TBL] [Abstract][Full Text] [Related]
27. Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020.
Terças-Trettel ACP; Muraro AP; Andrade ACS; Oliveira EC
Rev Assoc Med Bras (1992); 2022 Jul; 68(7):928-934. PubMed ID: 35946770
[TBL] [Abstract][Full Text] [Related]
28. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.
Hasan T; Pham TN; Nguyen TA; Le HTT; Van Le D; Dang TT; Van TD; Pham YN; Nguyen HV; Tran GL; Nguyen VTC; Nguyen TT; Truong VQ; Dao TH; Le CT; Truong NT; Vo HT; Le PT; Nguyen TT; Van Luu V; Nguyen VD; Toelle BG; Marks GB; Fox GJ
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34208212
[TBL] [Abstract][Full Text] [Related]
29. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
32. Changes in the seroprevalence and risk factors between the first and second waves of COVID-19 in a metropolis in the Brazilian Amazon.
da Silva Torres MK; Lopes FT; de Lima ACR; Cordeiro Lima CN; Dos Santos Brito WR; Gonçalves JSS; Dos Santos Oliveira O; de Oliveira Freitas V; Dos Santos BC; Santos de Sousa R; Carvalho Gomes JL; Sarmento Botelho BJ; Alves Correa AC; Machado LFA; Martins Feitosa RN; Lima SS; Cayres Vallinoto IMV; Vallinoto ACR
Front Cell Infect Microbiol; 2022; 12():932563. PubMed ID: 36189360
[TBL] [Abstract][Full Text] [Related]
33. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
[TBL] [Abstract][Full Text] [Related]
34. Testing for COVID-19: a few points to remember.
Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Rodrigues Bomfim R; Grespan R; Santana Rodrigues L; Dos Santos DM; de Sá Resende A; de Lima Silva N; da Silva Santos ACR; Dantas Araújo JM; de Souza MF; de Oliveira Góes MA; Santana Santos V; Martins-Filho PR
Epidemiol Infect; 2021 May; 149():e130. PubMed ID: 34001292
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
[TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors.
Pedersen OB; Nissen J; Dinh KM; Schwinn M; Kaspersen KA; Boldsen JK; Didriksen M; Dowsett J; Sørensen E; Thørner LW; Larsen MAH; Grum-Schwensen B; Sækmose S; Paulsen IW; Frisk NLS; Brodersen T; Vestergaard LS; Rostgaard K; Mølbak K; Skov RL; Erikstrup C; Ullum H; Hjalgrim H
Clin Infect Dis; 2021 Nov; 73(9):e2962-e2969. PubMed ID: 33103182
[TBL] [Abstract][Full Text] [Related]
39. Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
Han J; Baek HJ; Noh E; Yoon K; Kim JA; Ryu S; Lee KO; Park NY; Jung E; Kim S; Lee H; Hwang YS; Jung J; Lee HJ; Cho SI; Oh S; Kim M; Oh CM; Yu B; Hong YS; Kim K; Jung SJ; Han MA; Lee MS; Lee JJ; Hwangbo Y; Yim HW; Kim YM; Lee J; Lee WY; Park JH; Oh S; Jo HS; Kim H; Kang G; Nam HS; Lee JH; Oh GJ; Shin MH; Ryu S; Hwang TY; Park SW; Kim SK; Seol R; Park KS; Kim SY; Kwon JW; Kim SS; Kim B; Lee JW; Jang EY; Kim AR; Nam J; ; Lee SY; Kim DH
Epidemiol Health; 2023; 45():e2023075. PubMed ID: 37591786
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
